In Vitro Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles against Feline Infectious Peritonitis Virus and Pharmacokinetics Study in Cats

Table 7

Measurement of immune-related protein concentrations (pg/mL) of different treatment groups in infected cells at 24 h.

Cytokine/chemokine	Uninfected control cells	Infected cells	Infected cells treated with curcumin	Infected cells treated with Cur-CS nanoparticles
PDGF-BB	^a	^b	^b	^b
IL-8	^a	^d	^c	^b
KC	^a	^c	^bc	^b
SDF-1	^a	^b	^b	^b
RANTES	^a	^d	^c	^b
MCP-1	^a	^c	^c	^bc
TNFα	^a	^b	^b	^b
IL-18	<31.53	^c	^ab	^a

Data are presented as where each experiment was performed in duplicate and analysed using one-way ANOVA and post hoc Duncan multiple test. For each cytokine/chemokine, means within a row with different roman letters were significantly different () from each other. Cur-CS: curcumin-encapsulated chitosan.